CLINICAL_TRIALS
trial_result
· 2018-06-19
Clinical Trial Update: A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention. [Phase 2]
Summary
Phase 2 trial assessing long-term safety and efficacy of erenumab (AMG 334) for chronic migraine prevention is completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Treatment for Prevention of Chronic Migraine | Phase 2 | Status: COMPLETED | Results posted: 2018-06-19